Weight-based heparin dosing: clinical response and resource utilization
Authors:
- Aileen B. LuzierALAileen B. Luzier
- John A. DonovanJDJohn A. Donovan
- Hawari I. FerasHFHawari I. Feras
- Alan ForrestAFAlan Forrest
- 1 July 1998
- journal article
- clinical trial
- Published by Elsevier in Clinical Therapeutics
- Vol. 20 (4) , 699-710
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Inability of the activated partial thromboplastin time to predict heparin levels. Time to reassess guidelines for heparin assaysArchives of internal medicine (1960), 1997
- Aging and heparin-related bleedingArchives of internal medicine (1960), 1996
- Activated Partial Thromboplastin Time and Outcome After Thrombolytic Therapy for Acute Myocardial InfarctionCirculation, 1996
- Appropriate use of heparin. Empiric vs nomogram-based dosingArchives of internal medicine (1960), 1995
- Optimal therapeutic level of heparin therapy in patients with venous thrombosisArchives of internal medicine (1960), 1992
- Physician practices in the treatment of pulmonary embolism and deep venous thrombosisArchives of internal medicine (1960), 1988
- Continuous Intravenous Heparin Compared with Intermittent Subcutaneous Heparin in the Initial Treatment of Proximal-Vein ThrombosisNew England Journal of Medicine, 1986
- Drug Disposition in Obese HumansClinical Pharmacokinetics, 1986
- Audit of control of heparin treatment.BMJ, 1985
- Predictors of bleeding during heparin therapyJAMA, 1980